Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes

BACKGROUND: Recombinant Growth hormone (rGH) therapy is approved in many countries for treatment of short stature in a number of childhood diagnoses. Despite the increasing body of international literature on rGH use, there is paucity of data on rGH use in Kuwait and the broader Middle-East which sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Abdulrazzaq, Dalia, Al-Taiar, Abdullah, Hassan, Kholoud, Al-Basari, Iman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668632/
https://www.ncbi.nlm.nih.gov/pubmed/26630987
http://dx.doi.org/10.1186/s12902-015-0073-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668632/
https://www.ncbi.nlm.nih.gov/pubmed/26630987
http://dx.doi.org/10.1186/s12902-015-0073-7

Ejemplares similares